|EKGGF -- USA Stock|| |
USD 0.04 0.0012 3.09%
Chairman of the Board
Dr. Anatoly Langer M.D. is Chairman of the Board of the Company. He is graduated from the University of Manitoba in 1982 and completed his Internal Medicine and Cardiology training at the University of Toronto in 1987. He is a fellow of the American College of Cardiology and Canadian Royal College of Physicians and Surgeons. After two years as a Heart and Stroke Foundation Research Fellow he became a director of the Coronary Care Unit at St. Michael Hospital in Toronto Canada . In 1996 Dr. Langer founded the Canadian Heart Research Centre with the goal of improving the care of cardiovascular patients through clinical trials research and education. Dr. Langer has over 200 peer reviewed publications abstracts and book chapters. His areas of interest and research include pathophysiology and the management of acute and stable coronary syndromes as well as the treatment and prevention of cardiovascular disease. Currently Dr. Langer is a Professor of Medicine at the University of Toronto and a staff cardiologist at St Michael Hospital. He is Chair of the Canadian Heart Research Centre in Toronto . Dr. Langer has research experience in the conduct of clinical trials with over 15 years of experience in protocol design study coordination and data management.
Chairman Since 2010
The company has return on total asset (ROA)
of 6.09 %
which means that it generated profit of $6.09 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of (20.93) %
meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 468.64 K in total debt with debt to equity ratio (D/E) of 143.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. CardioComm Solutions has Current Ratio of 1.36 which is within standard range for the sector.
CardioComm Solutions, Inc., together with its subsidiary, CardioView Inc., develops software and hardware products, and core laboratory reading services related to electrocardiogram and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada. CardioComm Solutions operates under Health Information Services classification in USA and traded on OTC Market.CardioComm Solutions (EKGGF) is traded on OTC Market in USA. It is located in 259 Yorkland Road and employs 10 people.
CardioComm Solutions Leadership Team
|Etienne Grima, CEO|
|William Smith, Director|
|Steven Benyo, Director, CPA|
|Robert Caines, Director|
|Yury Levin, Director|
|David Newman, Director, Ph.D|
|Simi Grosman, Director|
|John Foote, Director, Ph.D|
|Anatoly Langer, Chairman|
|John Overall, CFO|
|Margaret Helms, Director|
|Wendy Hsieh, CFO|
Stock Performance Indicators
Macroaxis portfolio users are insensible in their opinion about investing in CardioComm Solutions. What is your opinion about investing in CardioComm Solutions? Are you bullish or bearish?
and pair trading evaluation for CardioComm Solutions and Facebook
. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Additionally see Investing Opportunities
. Please also try Premium Stories
module to follow macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.